IL160539A0 - Anti-influenzal agents - Google Patents

Anti-influenzal agents

Info

Publication number
IL160539A0
IL160539A0 IL16053902A IL16053902A IL160539A0 IL 160539 A0 IL160539 A0 IL 160539A0 IL 16053902 A IL16053902 A IL 16053902A IL 16053902 A IL16053902 A IL 16053902A IL 160539 A0 IL160539 A0 IL 160539A0
Authority
IL
Israel
Prior art keywords
influenzal
agents
influenzal agents
Prior art date
Application number
IL16053902A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Techno Network Shikoku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Techno Network Shikoku Co Ltd filed Critical Boehringer Ingelheim Int
Publication of IL160539A0 publication Critical patent/IL160539A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16053902A 2001-09-04 2002-09-03 Anti-influenzal agents IL160539A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001267236 2001-09-04
PCT/JP2002/008940 WO2003020258A1 (fr) 2001-09-04 2002-09-03 Medicament contre la grippe de type a

Publications (1)

Publication Number Publication Date
IL160539A0 true IL160539A0 (en) 2004-07-25

Family

ID=19093396

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16053902A IL160539A0 (en) 2001-09-04 2002-09-03 Anti-influenzal agents

Country Status (12)

Country Link
US (1) US20040242700A1 (hu)
EP (1) EP1437134A4 (hu)
KR (1) KR20040045429A (hu)
CN (1) CN1267091C (hu)
BR (1) BR0212232A (hu)
CA (1) CA2459492A1 (hu)
HK (1) HK1069526A1 (hu)
HU (1) HUP0402299A3 (hu)
IL (1) IL160539A0 (hu)
MX (1) MXPA04002066A (hu)
NZ (1) NZ532019A (hu)
WO (1) WO2003020258A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
US20080319087A1 (en) * 2005-08-25 2008-12-25 Anke Esperester Use of Ambroxol for the Treatment of Rhinovirus Infections
US20100121083A1 (en) * 2007-03-19 2010-05-13 Yuuzou Tsuchida Anti-viral agent
JP5337405B2 (ja) 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
WO2019018247A1 (en) 2017-07-16 2019-01-24 Neuere, Llc USE OF AMBROXOL TO IMPROVE AND / OR EXTEND THE LIFETIME IN GOOD HEALTH, LIFETIME AND / OR MENTAL ACUITY
EP3743039A1 (en) 2018-01-26 2020-12-02 Neuere, LLC Use of ambroxol to improve skin barrier function
US20220331408A1 (en) 2019-07-09 2022-10-20 Genethon Treatment of glycogen storage disease (gsd)
WO2021255129A1 (en) * 2020-06-16 2021-12-23 Spedding Research Solutions, Sas Novel use of a modulator of glucosylceramide degradation for viral infections
KR20240095271A (ko) 2021-10-28 2024-06-25 지위, 엘엘씨 치료적 사용을 위한 암브록솔의 변형된 형태

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610997A1 (de) * 1986-04-02 1987-10-15 Krewel Werke Gmbh Ambroxol-nasenspray
CA2146637C (en) * 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
WO1994014476A1 (en) * 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
JPH06287144A (ja) * 1993-02-03 1994-10-11 Takeda Chem Ind Ltd かぜ薬製剤
CA2170488A1 (en) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
EP0841947A1 (en) * 1995-07-28 1998-05-20 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US5885594A (en) * 1997-03-27 1999-03-23 The Procter & Gamble Company Oral compositions having enhanced mouth-feel

Also Published As

Publication number Publication date
KR20040045429A (ko) 2004-06-01
HUP0402299A3 (en) 2008-04-28
EP1437134A1 (en) 2004-07-14
MXPA04002066A (es) 2005-02-17
US20040242700A1 (en) 2004-12-02
HUP0402299A2 (hu) 2005-02-28
HK1069526A1 (en) 2005-05-27
CA2459492A1 (en) 2003-03-13
BR0212232A (pt) 2004-10-05
NZ532019A (en) 2007-04-27
CN1267091C (zh) 2006-08-02
EP1437134A4 (en) 2009-03-11
CN1549708A (zh) 2004-11-24
WO2003020258A1 (fr) 2003-03-13

Similar Documents

Publication Publication Date Title
DE60209787D1 (en) Flächiges implantat
DE50202400D1 (en) Baw-resonator
DE50201180D1 (en) Organopolysiloxan/polyharnstoff/polyurethan-blockcopolymere
DE60213216D1 (en) Metalloproteinaseinhibitoren
DE50209614D1 (en) 2-heteroarylcarbonsäureamide
DE50211022D1 (en) Heteroarylcarbonsäureamide
DE60210819D1 (en) Pyrazolopyridazinderivate
DE60141364D1 (en) Polyphenylensulfidharzzusammensetzung
DE60141362D1 (en) Ösophagus-stoma-knopf
DE50202633D1 (en) Ophthalmoskop
AU2002360430A8 (en) 14-methyl-epothilones
DE60107296D1 (en) Kabelverstärkerverbindungsanordnung
IL160539A0 (en) Anti-influenzal agents
DE60204140D1 (en) 5-ethyl-imidazotriazinone
DE50203686D1 (en) Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate
DE50206483D1 (en) Displaymodul
DE50201028D1 (en) Diarylgelbpigmentpraeparationen
DE50214962D1 (en) Heterocyclylarylsulfonamide
DE60206072D1 (en) Aroylpyridinone
AU2002313943A8 (en) Electromobile
GB0106987D0 (en) Immunotherapeuitic agent
GB0122162D0 (en) Agent
AU2001100134A4 (en) Enviro-trap
CA93959S (en) Tilt-latch
CA93126S (en) Titlt-latch